- The role of transcription factors PU.1 and GATA-1 during leukemia differentiationPublication without faculty affiliation
- TRANSCRIPTION FACTOR PU.1 IS A TARGET OF 5-AZACITIDINE DURING DIFFERENTIATION THERAPY OF MYELODYSPLASTIC SYNDROMEPublication without faculty affiliation
- Sustained PU.1 Levels Balance Cell-Cycle Regulators to Prevent Exhaustion of Adult Hematopoietic Stem Cells2013 | Central Library of Charles University
- Interconversion between Tumorigenic and Differentiated States in Acute Myeloid Leukemia2019 | First Faculty of Medicine
- Epigenetic Control of SPI1 Gene by CTCF and ISWI ATPase SMARCA52014 | First Faculty of Medicine
- 5-Azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity2012 | First Faculty of Medicine
- PU.1 Activation Relieves GATA-1-Mediated Repression of Cebpa and Cbfb during Leukemia Differentiation2009 | First Faculty of Medicine
- The role of PU.1 and GATA-1 transcription factors during normal and leukemogenic hematopoiesis2010 | First Faculty of Medicine
- PU.1 expression is modulated by the balance of functional sense and antisense RNAs regulated by a shared cis-regulatory element2008 | Central Library of Charles University
- Oncogenic microRNA-155 and its target PU.1: an integrative gene expression study in six of the most prevalent lymphomas2015 | First Faculty of Medicine
- Combined Approach to Leukemic Differentiation Using Transcription Factor PU.1-Enhancing Agents2022 | First Faculty of Medicine
- Epigenetic silencing of the oncogenic miR-17-92 cluster during PU.1-directed macrophage differentiation2011 | First Faculty of Medicine
- PU.1-c-Jun interaction is crucial for PU.1 function in myeloid development2022 | Second Faculty of Medicine